CDC7 serine/threonine protein kinase inhibitors (Amgen)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCDC7 serine/threonine protein kinase inhibitors (Amgen)
Drug Alias Namecell division cycle-7 serine-threonine protein kinase inhibitors (Amgen)azole-based CDC7 inhibitors (Amgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle 7-related protein kinase inhibitors
TargetsCell division cycle 7-related protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A